Status
Conditions
Treatments
About
The aim of this study is to investigate the effects of non invasive brain stimulation - NIBS - techniques (Electroconvulsivotherapy - ECT, transcranial Direct Current Stimulation - tDCS, repetitive transcranial magnetic stimulation - rTMS) on serum Brain Derived Neurotrophic factor (BDNF) levels in patients with depression and schizophrenia. Four blood samples will be collected in each participants, one before the NIBS sessions, and 3 after the completion of NIBS protocols: one immediately after the end of the NIBS sessions, a second one week after and a last one month after. Two blood samples separated by one month will also be collected in a a group of healthy volunteers.
Full description
The hypothesis is that NIBS will modulate BDNF levels and that the modification in serum BDNF levels will be correlated with clinical improvements in the sample of patients.
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
Exclusion criteria
In the depression and schizophrenia group:
Primary purpose
Allocation
Interventional model
Masking
200 participants in 8 patient groups
Loading...
Central trial contact
lydie sartelet
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal